Feed Preview

Fast Growing

Decision Making & Cognitive Aging

Decision Making & Cognitive Aging diagram by Pressman et al, PLOS One
Pressman et al, PLOS One

While abilities like vocabulary resist aging, other abilities such as memory, decision-making, and reasoning, gradually decline. Here is the latest research on decision-making and cognitive aging.

Top 20 most recent papers
Continuum : Lifelong Learning in Neurology

Epidemiology and Primary Prevention of Stroke

Continuum : Lifelong Learning in NeurologyApril 1, 2020
Karen Furie
Journal of Anesthesia

Preoperative cognitive impairment associated with oversedation during recovery from anesthesia

Journal of AnesthesiaMarch 31, 2020
S Chandralekha KruthiventiToby N Weingarten
Alzheimer Disease and Associated Disorders

Identifying Adaptive and Maladaptive Behaviors Following a Diagnosis of Mild Cognitive Impairment

Alzheimer Disease and Associated DisordersMarch 29, 2020
Allison GibsonGregory A Jicha
Journal of Managed Care & Specialty Pharmacy

Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment

Journal of Managed Care & Specialty PharmacyApril 1, 2020
Devender S DhandaJosh J Carlson
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition

Volunteering in older adulthood is associated with activity engagement and cognitive functioning

Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and CognitionApril 1, 2020
Hayley GuineyLiana Machado
Clinical Oncology : a Journal of the Royal College of Radiologists

Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice

Clinical Oncology : a Journal of the Royal College of RadiologistsMarch 29, 2020
M EvisonS Popat
American Journal of Epidemiology

Women's Work-Family Histories and Cognitive Performance in Later Life

American Journal of EpidemiologyMarch 29, 2020
Erin IceSarah Burgard
World Journal of Urology

Treatment of urinary tract infections in the old and fragile

World Journal of UrologyMarch 30, 2020
Guohua ZengAyberk Bayramgil
Current Oncology

Humanism in global oncology curricula: an emerging priority

Current OncologyMarch 29, 2020
M GiulianiJ Frambach
Journal of Managed Care & Specialty Pharmacy

One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults

Journal of Managed Care & Specialty PharmacyApril 1, 2020
Ashley I MartinezDaniela C Moga
5
Frontiers in Nutrition

Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty

Frontiers in NutritionMarch 29, 2020
Liliana C BaptistaThomas W Buford
9
1
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences

Linear and Non-Linear Age Trajectories of Language Use: A Laboratory Observation Study of Couples' Conflict Conversations

The Journals of Gerontology. Series B, Psychological Sciences and Social SciencesApril 1, 2020
Minxia LuoBurcu Demiray
Brain and Neuroscience Advances

Precommissural and postcommissural fornix microstructure in healthy aging and cognition

Brain and Neuroscience AdvancesMarch 29, 2020
Bethany M CoadClaudia Metzler-Baddeley
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/decision-making-cognitive-aging/714719b9-7cdb-45c9-b1d9-b877192653ad